BECN1 and ovarian carcinoma: A large amount of studies have reported that Beclin 1 expression is reduced in various human cancers, including breast cancers, glioblastomas, ovarian cancers, hepatocellular cancers, esophageal cancers and thyroid cancers compared to normal tissue.